News Daily News Aspirin Use by Elderly Patients After Vascular Events Linked to More Bleeding, Especially GI Bleeds Michael O'Riordan June 14, 2017
News Daily News Use of DAPT Score Following PCI Validated in PRODIGY Study Yael L. Maxwell June 12, 2017
News Conference News SCAI 2017 Minority Women Face 50% Increased Risk of Death/MI After PCI Compared With White Men at 1 Year L.A. McKeown May 18, 2017
News Conference News EuroPCR 2017 BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI Michael O'Riordan May 18, 2017
News Conference News EuroPCR 2017 DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit Michael O'Riordan May 16, 2017
News Conference News SCAI 2017 Domo Arigato: High Success Rates, Low Radiation With Both Radial and Femoral Robotic PCI L.A. McKeown May 12, 2017
News Features Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions Michael O'Riordan May 08, 2017
News Features Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe Shelley Wood May 05, 2017
Presentation Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD April 25, 2017
News Daily News Long-term MI Risk Among Stable CAD Patients: Some Clues From CORONOR Shelley Wood April 24, 2017
News Daily News Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance Michael O'Riordan April 18, 2017
News Conference News ACC 2017 ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience Michael O'Riordan March 18, 2017
News Conference News ACC 2017 FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS Michael O'Riordan March 18, 2017
News Conference News CRT 2017 Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate Michael O'Riordan February 21, 2017